AAAAAA

   
Results: 1-25 | 26-50 | 51-64
Results: 1-25/64
THERAPEUTIC TARGETING OF TRANSCRIPTION IN ACUTE PROMYELOCYTIC LEUKEMIA BY USE OF AN INHIBITOR OF HISTONE DEACETYLASE
Authors: WARRELL RP HE LZ RICHON V CALLEJA E PANDOLFI PP
Citation: Rp. Warrell et al., THERAPEUTIC TARGETING OF TRANSCRIPTION IN ACUTE PROMYELOCYTIC LEUKEMIA BY USE OF AN INHIBITOR OF HISTONE DEACETYLASE, Journal of the National Cancer Institute, 90(21), 1998, pp. 1621-1625
PML IS ESSENTIAL FOR MULTIPLE APOPTOTIC PATHWAYS
Authors: WANG ZG RUGGERO D RONCHETTI S ZHONG S GABOLI M RIVI R PANDOLFI PP
Citation: Zg. Wang et al., PML IS ESSENTIAL FOR MULTIPLE APOPTOTIC PATHWAYS, Nature genetics, 20(3), 1998, pp. 266-272
PTEN IS ESSENTIAL FOR EMBRYONIC-DEVELOPMENT AND TUMOR SUPPRESSION
Authors: DICRISTOFANO A PESCE B CORDONCARDO C PANDOLFI PP
Citation: A. Dicristofano et al., PTEN IS ESSENTIAL FOR EMBRYONIC-DEVELOPMENT AND TUMOR SUPPRESSION, Nature genetics, 19(4), 1998, pp. 348-355
HOMOZYGOUS C1Q DEFICIENCY CAUSES GLOMERULONEPHRITIS ASSOCIATED WITH MULTIPLE APOPTOTIC BODIES
Authors: BOTTO M DELLAGNOLA C BYGRAVE AE THOMPSON EM COOK HT PETRY F LOOS M PANDOLFI PP WALPORT MJ
Citation: M. Botto et al., HOMOZYGOUS C1Q DEFICIENCY CAUSES GLOMERULONEPHRITIS ASSOCIATED WITH MULTIPLE APOPTOTIC BODIES, Nature genetics, 19(1), 1998, pp. 56-59
DISTINCT INTERACTIONS OF PML-RAR-ALPHA AND PLZF-RAR-ALPHA WITH CO-REPRESSORS DETERMINE DIFFERENTIAL RESPONSES TO RA IN APL
Authors: HE LZ GUIDEZ F TRIBIOLI C PERUZZI D RUTHARDT M ZELENT A PANDOLFI PP
Citation: Lz. He et al., DISTINCT INTERACTIONS OF PML-RAR-ALPHA AND PLZF-RAR-ALPHA WITH CO-REPRESSORS DETERMINE DIFFERENTIAL RESPONSES TO RA IN APL, Nature genetics, 18(2), 1998, pp. 126-135
ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS
Authors: GABOLI M GANDINI D DELVA L WANG ZG PANDOLFI PP
Citation: M. Gaboli et al., ACUTE PROMYELOCYTIC LEUKEMIA AS A MODEL FOR CROSS-TALK BETWEEN INTERFERON AND RETINOIC ACID PATHWAYS - FROM MOLECULAR-BIOLOGY TO CLINICAL-APPLICATIONS, Leukemia & lymphoma, 30(1-2), 1998, pp. 11
INHIBITION OF CELL-PROLIFERATION BY THE INTERFERON-INDUCIBLE 204-GENE, A MEMBER OF THE IFI-200 CLUSTER
Authors: LEMBO M SACCHI C ZAPPADOR C BELLOMO G GABOLI M PANDOLFI PP GARIGLIO M LANDOLFO S
Citation: M. Lembo et al., INHIBITION OF CELL-PROLIFERATION BY THE INTERFERON-INDUCIBLE 204-GENE, A MEMBER OF THE IFI-200 CLUSTER, Oncogene, 16(12), 1998, pp. 1543-1551
WESTERN STUDY OF ARSENIC TRIOXIDE (AS2O3) IN PATIENTS WITH RELAPSED AND OR REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA/
Authors: SOIGNET SL MASLAK P CHEN YW CALLEJA E PANDOLFI PP SCHEINBERG DA WARRELL RP
Citation: Sl. Soignet et al., WESTERN STUDY OF ARSENIC TRIOXIDE (AS2O3) IN PATIENTS WITH RELAPSED AND OR REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA/, Annals of oncology, 9, 1998, pp. 675-675
KNOCKING IN AND OUT GENES AND TRANS GENES - THE USE OF THE ENGINEEREDMOUSE TO STUDY NORMAL AND ABERRANT HEMATOPOIESIS
Authors: PANDOLFI PP
Citation: Pp. Pandolfi, KNOCKING IN AND OUT GENES AND TRANS GENES - THE USE OF THE ENGINEEREDMOUSE TO STUDY NORMAL AND ABERRANT HEMATOPOIESIS, Seminars in hematology, 35(2), 1998, pp. 136-148
ROLE OF PML IN CELL-GROWTH AND THE RETINOIC ACID PATHWAY
Authors: WANG ZG DELVA L GABOLI M RIVI R GIORGIO M CORDONCARDO C GROSVELD F PANDOLFI PP
Citation: Zg. Wang et al., ROLE OF PML IN CELL-GROWTH AND THE RETINOIC ACID PATHWAY, Science, 279(5356), 1998, pp. 1547-1551
COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE
Authors: SOIGNET SL MASLAK P WANG ZG JHANWAR S CALLEJA E DARDASHTI LJ CORSO D DEBLASIO A GABRILOVE J SCHEINBERG DA PANDOLFI PP WARRELL RP
Citation: Sl. Soignet et al., COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE, The New England journal of medicine, 339(19), 1998, pp. 1341-1348
MOLECULAR-CLONING AND CHARACTERIZATION OF P56(DOK-2) DEFINES A NEW FAMILY OF RASGAP-BINDING PROTEINS
Authors: DICRISTOFANO A CARPINO N DUNANT N FRIEDLAND G KOBAYASHI R STRIFE A WISNIEWSKI D CLARKSON B PANDOLFI PP RESH MD
Citation: A. Dicristofano et al., MOLECULAR-CLONING AND CHARACTERIZATION OF P56(DOK-2) DEFINES A NEW FAMILY OF RASGAP-BINDING PROTEINS, The Journal of biological chemistry, 273(9), 1998, pp. 4827-4830
4-OXORETINOL, A METABOLITE OF RETINOL IN THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE NB4, INDUCES CELL-GROWTH ARREST AND GRANULOCYTIC DIFFERENTIATION
Authors: FARIA TN RIVI R DERGUINI F PANDOLFI PP GUDAS LJ
Citation: Tn. Faria et al., 4-OXORETINOL, A METABOLITE OF RETINOL IN THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE NB4, INDUCES CELL-GROWTH ARREST AND GRANULOCYTIC DIFFERENTIATION, Cancer research, 58(9), 1998, pp. 2007-2013
COMPLETE REMISSION AFTER CLINICALLY INDUCED-DIFFERENTIATION AND APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA BY ARSENIC TRIOXIDE
Authors: SOIGNET SL MASLAK P CHEN YW CALLEJA E PANDOLFI PP SCHEINBERG DA WARRELL RP
Citation: Sl. Soignet et al., COMPLETE REMISSION AFTER CLINICALLY INDUCED-DIFFERENTIATION AND APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA BY ARSENIC TRIOXIDE, British Journal of Haematology, 102(1), 1998, pp. 225-225
ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML-RAR-ALPHA INDEPENDENT MANNER
Authors: WANG ZG RIVI R DELVA L KONIG A SCHEINBERG DA GAMBACORTIPASSERINI C GABRILOVE JL WARRELL RP PANDOLFI PP
Citation: Zg. Wang et al., ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML-RAR-ALPHA INDEPENDENT MANNER, Blood, 92(5), 1998, pp. 1497-1504
THE BCL-6 PROTOONCOGENE CONTROLS GERMINAL-CENTER FORMATION AND TH2-TYPE INFLAMMATION
Authors: YE BH CATTORETTI G SHEN QO ZHANG JD HAWE N DEWAARD R LEUNG C NOURISHIRAZI M ORAZI A CHAGANTI RSK ROTHMAN P STALL AM PANDOLFI PP DALLAFAVERA R
Citation: Bh. Ye et al., THE BCL-6 PROTOONCOGENE CONTROLS GERMINAL-CENTER FORMATION AND TH2-TYPE INFLAMMATION, Nature genetics, 16(2), 1997, pp. 161-170
THE CHROMOSOME MAKE-UP OF MOUSE EMBRYONIC STEM-CELLS IS PREDICTIVE OFSOMATIC AND GERM-CELL CHIMERISM
Authors: LONGO L BYGRAVE A GROSVELD FG PANDOLFI PP
Citation: L. Longo et al., THE CHROMOSOME MAKE-UP OF MOUSE EMBRYONIC STEM-CELLS IS PREDICTIVE OFSOMATIC AND GERM-CELL CHIMERISM, Transgenic research, 6(5), 1997, pp. 321-328
ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/
Authors: HE LZ TRIBIOLI C RIVI R PERUZZI D PELICCI PG SOARES V CATTORETTI G PANDOLFI PP
Citation: Lz. He et al., ACUTE-LEUKEMIA WITH PROMYELOCYTIC FEATURES IN PML RAR-ALPHA TRANSGENIC MICE/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(10), 1997, pp. 5302-5307
MURINE EMBRYONIC STEM-CELLS WITHOUT PIG-A GENE ACTIVITY ARE COMPETENTFOR HEMATOPOIESIS WITH THE PNH PHENOTYPE BUT NOT FOR CLONAL EXPANSION
Authors: ROSTI V TREMML G SOARES V PANDOLFI PP LUZZATTO L BESSLER M
Citation: V. Rosti et al., MURINE EMBRYONIC STEM-CELLS WITHOUT PIG-A GENE ACTIVITY ARE COMPETENTFOR HEMATOPOIESIS WITH THE PNH PHENOTYPE BUT NOT FOR CLONAL EXPANSION, The Journal of clinical investigation, 100(5), 1997, pp. 1028-1036
GENE REARRANGEMENTS IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors: KALANTRY S DELVA L GABOLI M GANDINI D GIORGIO M HAWE N HE LZ PERUZZI D RIVI R TRIBIOLI C WANG ZG ZHANG H PANDOLFI PP
Citation: S. Kalantry et al., GENE REARRANGEMENTS IN THE MOLECULAR PATHOGENESIS OF ACUTE PROMYELOCYTIC LEUKEMIA, Journal of cellular physiology, 173(2), 1997, pp. 288-296
COMPARATIVE ACTIVITY OF MELARSOPROL AND ARSENIC TRIOXIDE IN CHRONIC B-CELL LEUKEMIA LINES
Authors: KONIG A WRAZEL L WARRELL RP RIVI R PANDOLFI PP JAKUBOWSKI A GABRILOVE JL
Citation: A. Konig et al., COMPARATIVE ACTIVITY OF MELARSOPROL AND ARSENIC TRIOXIDE IN CHRONIC B-CELL LEUKEMIA LINES, Blood, 90(2), 1997, pp. 562-570
EXPRESSION OF PU.1 IN THE THYMUS RESULTS IN ALTERED T-CELL DEVELOPMENT
Authors: KLEMSZ MJ GABOLI M HROMAS R PANDOLFI PP
Citation: Mj. Klemsz et al., EXPRESSION OF PU.1 IN THE THYMUS RESULTS IN ALTERED T-CELL DEVELOPMENT, Blood, 90(10), 1997, pp. 85-85
THERAPEUTIC TRIALS WITH RETINOIC ACID AND ARSENIC TRIOXIDE (ASO3) IN PML-RAR-ALPHA AND PLZF-RAR-ALPHA TRANSGENIC MICE AS MODELS OF APL
Authors: HE LZ PERUZZI D TRIBIOLI C WARRELL RP PANDOLFI PP
Citation: Lz. He et al., THERAPEUTIC TRIALS WITH RETINOIC ACID AND ARSENIC TRIOXIDE (ASO3) IN PML-RAR-ALPHA AND PLZF-RAR-ALPHA TRANSGENIC MICE AS MODELS OF APL, Blood, 90(10), 1997, pp. 825-825
MYELOID-LEUKEMIA IN PLZF RAR-ALPHA TRANSGENIC MICE/
Authors: HE LZ TRIBIOLI C PERUZZI D RUTHARD M CATTORETTI G PANDOLFI PP
Citation: Lz. He et al., MYELOID-LEUKEMIA IN PLZF RAR-ALPHA TRANSGENIC MICE/, Blood, 90(10), 1997, pp. 1427-1427
ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML RAR-ALPHA INDEPENDENT MANNER/
Authors: WANG ZG RIVI R DELVA L KONIG A SOIGNET S SCHEINBERG D GAMBACORTIPASSERINI C GABRILOVE JL WARRELL RP PANDOLFI PP
Citation: Zg. Wang et al., ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML RAR-ALPHA INDEPENDENT MANNER/, Blood, 90(10), 1997, pp. 1461-1461
Risultati: 1-25 | 26-50 | 51-64